Down 84%, Time Give: Should You Hold This IPO Stock?
When an IPO plunges, investors face a tough choice. This guide explains how to evaluate a stock that is down 84% and ...
Why Active Funds May Underperform Benchmarks discusses persistent headwinds, costs, and timing issues that hinder outperformance.
26,804 articlesWhen an IPO plunges, investors face a tough choice. This guide explains how to evaluate a stock that is down 84% and ...
Are there real opportunities hiding in plain sight? This guide explains why the market may be getting these stocks wr...
Investors await the July 14 CPI release to gauge the path of inflation and interest rates. This guide breaks down wha...
Investors often chase big biotech gains, but Viking Therapeutics stock really hinges on milestones and cash runway. T...
In 2025, Marathon Petroleum delivered a powerful cash-return story for shareholders. This article breaks down how the...
Many retirees have a big asset in their home, but counting home equity fund as retirement income is a risky move. Thi...
Moderna surged on pandemic-era demand. But what comes next? This piece examines why some investors are wary, what a t...
The Nasdaq down from high has created a disciplined buying moment for patient investors. This guide highlights five t...
A Brazilian fund made a sizable bet on MercadoLibre even as the stock slid over the past year. This article unpacks t...
Anthropic's IPO signals more than one company going public. It underscores a rising demand for AI compute, potentiall...
On a day when markets shuddered, TJX stood out as its shares rose. A mix of solid earnings signals, a supportive anal...
Sitting on a 1.1% S&P yield can feel underwhelming. These three dividend stocks double right now offer stronger incom...